FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Coast Quality Pharmacy, LLC dba Anazao Health Hydromorphone HCL and Bupivacaine HCL in all Recall

Hydromorphone HCL and Bupivacaine HCL in all strengths, all doses and all packaging, An…

Coast Quality Pharmacy, LLC dba Anazao Health · Tampa, FL

Risk level
Class II
Reported by FDA
Dec 18, 2019
Recall ID
D-0589-2020
Check your lot numberHow we source this data

Summary

Coast Quality Pharmacy, LLC dba Anazao Health recalled Hydromorphone HCL and Bupivacaine HCL in all starting Sep 3, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0589-2020 on Dec 18, 2019. Reason: Lack of Processing Controls; Environmental sampling revealed 1 CFU (Colony Forming Unit) identified as Talaromyces rotundus, a fungi. Status: Terminated.

Why it was recalled

Lack of Processing Controls; Environmental sampling revealed 1 CFU (Colony Forming Unit) identified as Talaromyces rotundus, a fungi.

Product description

Hydromorphone HCL and Bupivacaine HCL in all strengths, all doses and all packaging, AnazaoHealth 5710 Hoover Blvd Tampa, FL 33634.

Lot numbers, UPCs & expiration codes

All lots filled 08/26/2019 and dispensed 08/26-29/2019 remaining within expiry.

Where it was sold

Nationwide in the U.S.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0589-2020
Classification
Class II
Status
Terminated
Recall initiated
Sep 3, 2019
FDA report date
Dec 18, 2019
Quantity
Unknown
Recall type
Voluntary: Firm initiated
Recalling firm
Coast Quality Pharmacy, LLC dba Anazao Health

Original FDA data

Every field from FDA enforcement report D-0589-2020, exactly as published.

Show all FDA fields
City
Tampa
State
FL
Status
Terminated
Country
United States
Event ID
83996
Address
5710 Hoover Blvd
Code information
All lots filled 08/26/2019 and dispensed 08/26-29/2019 remaining within expiry.
Postal code
33634-5339
Report date
Dec 18, 2019
Product type
Drugs
Recall number
D-0589-2020
Classification
Class II
Recalling firm
Coast Quality Pharmacy, LLC dba Anazao Health
Product quantity
Unknown
Termination date
Dec 1, 2020
Reason for recall
Lack of Processing Controls; Environmental sampling revealed 1 CFU (Colony Forming Unit) identified as Talaromyces rotundus, a fungi.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Hydromorphone HCL and Bupivacaine HCL in all strengths, all doses and all packaging, AnazaoHealth 5710 Hoover Blvd Tampa, FL 33634.
Distribution pattern
Nationwide in the U.S.
Recall initiation date
Sep 3, 2019
Initial firm notification
Telephone
Center classification date
Dec 6, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0589-2020, published Dec 18, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls